ICAD
Icad, Inc.
A maker of AI software that helps doctors spot breast cancer on mammograms, iCAD traces its roots to 1984, when it launched as Howtek making image scanners. The company later renamed itself iCAD—short for "Intelligent Computer-Aided Detection"—after pivoting to medical imaging, and its ProFound software is used by clinics to flag suspicious findings. In 2025 the company was acquired by RadNet and folded into its DeepHealth portfolio.
CUSIP: 44934S206HealthcareUS1 holder
Total Value
$1.13M
Total Shares
701.5K
Net Share Change
+22.0K
Activity
1 buying
Investor
Value
Shares
Weight
Change
